Richard Mason's posts

N4 Pharma details plan to address Nuvec data inconsistencies (N4P)

N4 Pharma details plan to address Nuvec data inconsistencies (N4P)

Shares in N4 Pharma (LSE:N4P) sat flat at 4.4p on Monday after the firm announced that it has commissioned the University of Queensland to repeat original studies on its flagship Nuvec product. The update comes after N4’s share price collapsed last week when it...

Live Indices

Live commodities

Live FX Rates